Clinical Outcomes of Fludarabine and Melphalan with a 800 cGy Total Body Irradiation Conditioning Regimen in Patients with Refractory or Relapsed Aggressive Non-Hodgkin’s Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
ConclusionOur FMT regimen shows favorable transplant outcomes with relatively low-risk toxicities, so it may be a promising strategy for patients with relapsed or refractory aggressive NHL.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Cancer & Oncology | Chemotherapy | Chronic Leukemia | Hematology | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Toxicology | Transplants